Immuno oncology therapies with IL-2 conjugates

Disclosed herein are methods and uses relating to administering IL-2 conjugates or methods useful for the treatment of one or more indications, such as the treatment of proliferative diseases. Also described herein are pharmaceutical compositions and kits comprising one or more of the IL-2 conjugate...

Full description

Saved in:
Bibliographic Details
Main Authors PTACIN, JEROD, SHAWVER, LAURA, LEVEQUE, JOSEPH, MILLA, MARCOS, CAFFARO, CAROLINA E
Format Patent
LanguageChinese
English
Published 01.08.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed herein are methods and uses relating to administering IL-2 conjugates or methods useful for the treatment of one or more indications, such as the treatment of proliferative diseases. Also described herein are pharmaceutical compositions and kits comprising one or more of the IL-2 conjugates.
Bibliography:Application Number: TW202110137589